Encompass Health (EHC) EBIT: 2009-2025
Historic EBIT for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $12.5 million.
- Encompass Health's EBIT rose 8656.72% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.2 million, marking a year-over-year increase of 22408.76%. This contributed to the annual value of $61.9 million for FY2024, which is 38740.16% up from last year.
- According to the latest figures from Q3 2025, Encompass Health's EBIT is $12.5 million, which was up 8656.72% from $45.3 million recorded in Q2 2025.
- In the past 5 years, Encompass Health's EBIT registered a high of $49.5 million during Q1 2025, and its lowest value of -$239.7 million during Q2 2021.
- Over the past 5 years, Encompass Health's median EBIT value was $5.1 million (recorded in 2023), while the average stood at -$16.3 million.
- As far as peak fluctuations go, Encompass Health's EBIT plummeted by 119271.84% in 2021, and later skyrocketed by 127500.0% in 2025.
- Encompass Health's EBIT (Quarter) stood at -$2.6 million in 2021, then soared by 469.23% to $9.6 million in 2022, then tumbled by 46.88% to $5.1 million in 2023, then skyrocketed by 407.84% to $25.9 million in 2024, then tumbled by 51.74% to $12.5 million in 2025.
- Its EBIT was $12.5 million in Q3 2025, compared to $45.3 million in Q2 2025 and $49.5 million in Q1 2025.